Cargando…

Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis

BACKGROUND: Palmoplantar pustulosis (PPP) is initiated from the acrosyringium. However, it is unclear whether PPP should be considered a distinct entity or should be classified into the spectrum of pustular psoriasis, also known as palmoplantar pustular psoriasis (PPPP). OBJECTIVE: We evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae Hyung, Kim, Ji Su, Kwon, Ji Eun, Park, Bumhee, Lee, Eun-So
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831310/
https://www.ncbi.nlm.nih.gov/pubmed/35221589
http://dx.doi.org/10.5021/ad.2022.34.1.7
_version_ 1784648478528372736
author Kim, Tae Hyung
Kim, Ji Su
Kwon, Ji Eun
Park, Bumhee
Lee, Eun-So
author_facet Kim, Tae Hyung
Kim, Ji Su
Kwon, Ji Eun
Park, Bumhee
Lee, Eun-So
author_sort Kim, Tae Hyung
collection PubMed
description BACKGROUND: Palmoplantar pustulosis (PPP) is initiated from the acrosyringium. However, it is unclear whether PPP should be considered a distinct entity or should be classified into the spectrum of pustular psoriasis, also known as palmoplantar pustular psoriasis (PPPP). OBJECTIVE: We evaluated the differences in immunohistochemical staining in patients with PPP to determine whether they can be classified into two groups based on psoriatic properties or acrosyringeal properties. METHODS: Nineteen punch biopsy specimens diagnosed with PPP were collected. Antibodies were chosen for identifying the acrosyringeal properties of α-3-nicotine acetylcholine receptors (α-3-nAChR), psoriatic properties of interleukin (IL)-23 and IL-36R, inflammatory cell properties of human cathelicidin antimicrobial peptide 18/LL-37, IL-8, lipocalin-2 (LCN2), and CD3. The degree of staining of the epidermis was evaluated using the ordinal scale (0~3). The principal component analysis was used to derive principal components (PCs) of common variation between the stains, and the two groups were divided using PCs and cluster analysis. RESULTS: Three main PCs explained 64% of the total variance in PPP. PC1 (pustular psoriasis properties) showed a higher correlation with IL-36R. PC2 (acrosyringeal/inflammatory properties) showed a higher correlation with α-3-nAChR, IL-8, LCN2, and CD3. PC3 (psoriasis properties) showed a higher correlation with IL-23. PC1 showed a statistically significant difference (p=0.0284) between the two groups. We identified three PCs associated with the pathomechanisms of PPP. CONCLUSION: Although PC1 showed a statistically significant difference between the two groups, we did not identify differential protein expression related to the pathogenesis between PPP and PPPP.
format Online
Article
Text
id pubmed-8831310
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-88313102022-02-24 Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis Kim, Tae Hyung Kim, Ji Su Kwon, Ji Eun Park, Bumhee Lee, Eun-So Ann Dermatol Original Article BACKGROUND: Palmoplantar pustulosis (PPP) is initiated from the acrosyringium. However, it is unclear whether PPP should be considered a distinct entity or should be classified into the spectrum of pustular psoriasis, also known as palmoplantar pustular psoriasis (PPPP). OBJECTIVE: We evaluated the differences in immunohistochemical staining in patients with PPP to determine whether they can be classified into two groups based on psoriatic properties or acrosyringeal properties. METHODS: Nineteen punch biopsy specimens diagnosed with PPP were collected. Antibodies were chosen for identifying the acrosyringeal properties of α-3-nicotine acetylcholine receptors (α-3-nAChR), psoriatic properties of interleukin (IL)-23 and IL-36R, inflammatory cell properties of human cathelicidin antimicrobial peptide 18/LL-37, IL-8, lipocalin-2 (LCN2), and CD3. The degree of staining of the epidermis was evaluated using the ordinal scale (0~3). The principal component analysis was used to derive principal components (PCs) of common variation between the stains, and the two groups were divided using PCs and cluster analysis. RESULTS: Three main PCs explained 64% of the total variance in PPP. PC1 (pustular psoriasis properties) showed a higher correlation with IL-36R. PC2 (acrosyringeal/inflammatory properties) showed a higher correlation with α-3-nAChR, IL-8, LCN2, and CD3. PC3 (psoriasis properties) showed a higher correlation with IL-23. PC1 showed a statistically significant difference (p=0.0284) between the two groups. We identified three PCs associated with the pathomechanisms of PPP. CONCLUSION: Although PC1 showed a statistically significant difference between the two groups, we did not identify differential protein expression related to the pathogenesis between PPP and PPPP. The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2022-02 2022-01-27 /pmc/articles/PMC8831310/ /pubmed/35221589 http://dx.doi.org/10.5021/ad.2022.34.1.7 Text en Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Tae Hyung
Kim, Ji Su
Kwon, Ji Eun
Park, Bumhee
Lee, Eun-So
Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
title Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
title_full Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
title_fullStr Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
title_full_unstemmed Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
title_short Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
title_sort principal component analysis to differentiate patients with palmoplantar pustulosis from those with palmoplantar pustular psoriasis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831310/
https://www.ncbi.nlm.nih.gov/pubmed/35221589
http://dx.doi.org/10.5021/ad.2022.34.1.7
work_keys_str_mv AT kimtaehyung principalcomponentanalysistodifferentiatepatientswithpalmoplantarpustulosisfromthosewithpalmoplantarpustularpsoriasis
AT kimjisu principalcomponentanalysistodifferentiatepatientswithpalmoplantarpustulosisfromthosewithpalmoplantarpustularpsoriasis
AT kwonjieun principalcomponentanalysistodifferentiatepatientswithpalmoplantarpustulosisfromthosewithpalmoplantarpustularpsoriasis
AT parkbumhee principalcomponentanalysistodifferentiatepatientswithpalmoplantarpustulosisfromthosewithpalmoplantarpustularpsoriasis
AT leeeunso principalcomponentanalysistodifferentiatepatientswithpalmoplantarpustulosisfromthosewithpalmoplantarpustularpsoriasis